Company Overview and News
CALGARY, Alberta, 16 avr. 2018 (GLOBE NEWSWIRE) -- Avis aux médias - TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) a lancé aujourd’hui, aux parties intéressées, un appel de soumissions exécutoires portant sur de nouveaux contrats de services de transport à court terme du pétrole brut sur le système de pipeline Marketlink, entre Cushing, en Oklahoma, et les marchés sur la côte américaine du golfe du Mexique.
Midstream had a solid week, pulled higher by rallies in energy stocks and oil prices. Tuesday was the best day for MLPs all year (+3%) and Wednesday saw follow through, but the other 3 days were negative. Midstream performance was torn between improving sentiment for energy stocks and negative price action among income-oriented stocks like utilities and REITs, which under-performed on higher interest rates.
The Canadian province of Alberta may be willing to buy the Trans Mountain Pipeline system from Kinder Morgan Inc. (NYSE: KMI) in order to ensure a pathway to the Pacific Ocean for the province’s vast deposits of oil sands.
CALGARY, Alberta, April 10, 2018 (GLOBE NEWSWIRE) -- News Release – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) will hold its 2018 Annual Meeting of Shareholders on Friday, April 27, 2018 at 10 a.m. (MDT) / 12 p.m. (EDT) in Calgary, Alberta in the Roderick Mah Centre for Continuous Learning at Mount Royal University. A campus map can be found here.
TransCanada Corporation (TRP - Free Report) announced the commissioning of its Sundre Crossover Project in central Alberta. The project involves an investment of about $100 million. The company’s capability to transfer natural gas on TransCanada’s NOVA Gas Transmission Ltd. (“NGTL”) System to downstream pipelines and main markets in the Pacific Northwest and California will receive a boost from the project.
CALGARY, Alberta, 10 avr. 2018 (GLOBE NEWSWIRE) -- Avis aux médias – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) a annoncé aujourd’hui la mise en exploitation de son projet Sundre Crossover dans le centre de l’Alberta, augmentant ainsi la capacité de la société à transporter du gaz naturel sur le réseau de NOVA Gas Transmission Ltd (NGTL) de TransCanada jusqu’aux pipelines en aval et aux principaux marchés du nord-ouest du Pacifique et de la Californie.
Kinder Morgan Inc (KMI - Free Report) states that it has deferred bulk of work on its C$7.4-billion ($5.8 billion) Trans Mountain pipeline expansion and is likely to abandon the project if Canada’s provincial and federal governments cannot reach an agreement by May 31. Per Kinder Morgan Chairman Steve Kean, the plans to nearly triple the capacity of the Trans Mountain pipeline, which carries crude from Alberta's oil sands to a facility in the Pacific province of British Columbia, are likely to be scrapped if the ongoing legal disputes are not resolved by May 31.
TransCanada Corporation’s (TRP - Free Report) Keystone crude oil pipeline had a leak in November 2017, which is almost double the initial projection. This makes it one of the biggest U.S. inland spills since 2010. The company reported that about 9,700 barrels of oil were spilled on Nov 16, 2017 in rural South Dakota, up 94% from the original estimate of 5,000 barrels. However, the company did not disclose any details about the accident.
Ian's Million Fund "IMF" is a real-money portfolio that I've written about monthly since January 2016 here at Seeking Alpha. The portfolio is a largely buy-and-hold group of ~100 stocks. Each month, I buy 10-25 of the most compelling stocks available at then-current prices, deploying $1,000 of my capital plus accumulated dividends. If things go according to plan, this portfolio, began when I was 27, will hit one million dollars in equity in 2041 at age 52.
CALGARY, Alberta, April 03, 2018 (GLOBE NEWSWIRE) -- Media Advisory – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) today announced its Northwest Mainline Loop-Boundary Lake pipeline has been placed into service, completing the final section of its 2017 Expansion Program on the NOVA Gas Transmission Ltd. (NGTL) System. With the completion of winter construction activities, the 2017 Expansion Program represents a $1.
CALGARY, Alberta, April 02, 2018 (GLOBE NEWSWIRE) -- Media Advisory – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) today announced its Northwest Mainline Loop-Boundary Lake pipeline has been placed into service, completing the final section of its 2017 Expansion Program on the NOVA Gas Transmission Ltd. (NGTL) System. With the completion of winter construction activities, the 2017 Expansion Program represents a $1.
The shortage of pipelines and rail transportations has disrupted the production schedule of the companies in Western Canada. The companies had to slow down their activity levels due to difficulty in crude transportation. Oil sands companies such as Cenovus Energy Inc. (CVE - Free Report) , Suncor Energy Inc. (SU - Free Report) and Canadian Natural Resources Ltd. (CNQ - Free Report) witnessed a decline in share prices after Cenovus Energy announced a cut in its production at Christina Lake and Foster Creek complexes.
CALGARY, Alberta, March 23, 2018 (GLOBE NEWSWIRE) -- News Release – TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) announced today that its wholly-owned subsidiary, NOVA Gas Transmission Ltd. (NGTL), has filed an application with the National Energy Board for approval of a negotiated settlement with its customers and other interested parties on the annual costs required to operate the NGTL System for 2018 and 2019.
CALGARY, Alberta, 21 mars 2018 (GLOBE NEWSWIRE) -- Avis aux médias - La société TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada) a annoncé aujourd'hui qu'elle a complété avec succès son deuxième appel de soumissions exécutoires pour la capacité d'extension de la liaison au point de livraison d'exportation Empress/McNeill sur son système de NOVA Gas Transmission Ltd. (NGTL) en 2018. NGTL a offert 280 millions de pieds cubes par jour de service ferme, destiné à commencer en novembre 2021.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...